European Union eases its controls on Covid-19 vaccine exports

The Commission said that as of January it will no longer require vaccine producers to request special authorisation to export outside the 27-nation bloc

Coronavirus vaccine, Covid-19 vaccines
AP Brussels
2 min read Last Updated : Nov 26 2021 | 8:08 PM IST

The European Union said on Friday that it will ease its restrictions on exporting COVID-19 vaccines.

The Commission, the EU's executive arm, said that as of January it will no longer require vaccine producers to request special authorisation to export outside the 27-nation bloc.

Earlier this year when vaccines were still in short supply, the EU introduced a mechanism to keep some of the jabs it secured from AstraZeneca, the Anglo-Swedish drug company, from being diverted elsewhere.

The export control system, aimed at making sure large drug companies would respect their contracts, was used by the EU in March, when a shipment of more than a quarter million AstraZeneca vaccines destined for Australia was blocked from leaving.

When the dispute with AstraZeneca broke, the EU was lagging well behind the United States and other countries in COVID-19 vaccinations. According to Stella Kyriakides, the Commissioner for Health, the bloc has now vaccinated over 65% of the total EU population of some 450 million inhabitants.

The EU and AstraZeneca said in September that they reached a deal to end their legal battle over the slow pace of deliveries of the company's COVID-19 vaccines.

EU commission spokeswoman Dana Spinant said the transparency of exports will be ensured by a new monitoring mechanism that will provide the commission with companies' vaccine export data.

Spinant noted that the EU is the biggest global provider of COVID-19 vaccines, with over 1.3 billion doses exported to more than 150 countries.

Amid a new significant uptick in infections in the EU, European Commission President Ursula von der Leyen said vaccinations need to be stepped up further.

"We need to convince more people to get vaccinated," she said. "The good news is that we have enough vaccine doses. By the end of this week, Europe will have delivered 1 billion doses to our member states.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :EuropeEuropean UnionCoronavirus Vaccine

First Published: Nov 26 2021 | 8:08 PM IST

Next Story